جست‌وجوی استاد و پژوهشگر

Carmen Bergomمشاهده پروفایل

دانشیار

• Radiation Oncology
• Breast Cancer
• Tumor Microenvironment
• +۵ مورد دیگر

Carmen Bergom, MD, PhD, is an Associate Professor of Radiation Oncology at Washington University School of Medicine (WashU Medicine), where she joined the faculty in 2020. She holds secondary appointments in the Division of Cancer Biology and the Siteman Cancer Center. Her research focuses on leveraging genetic models to improve radiation therapy efficacy while mitigating radiation-induced cardiotoxicity , particularly in breast cancer patients. Key areas include radiation biology , tumor microenvironment , and cardio-oncology . Recent publications highlight her work in genetic mapping of radiation sensitivity (e.g., rat chromosome 3 variants), innovative imaging techniques (e.g., integrin-targeted PET), and clinical trial design for cardiovascular risk stratification. Her laboratory has pioneered the first genetic studies of radiation-induced cardiac dysfunction. Scientific awards include the Michael Fry Research Award (2021) and recognition as a Top Doctor in America (2018, 2019). She serves as Chair of the ASTRO Science Council Scientific Review Panel and co-chair of the Clinical and Experimental Research in Radiation Oncology meeting at ESTRO. Dr. Bergom treats breast cancer patients clinically and mentors students across all levels (undergraduate to postdoctoral). Her work bridges basic research with clinical applications , aiming to develop biomarkers and therapeutic targets for radiation oncology.

Kristina Schoonjansمشاهده پروفایل

دانشیار

• Bile acid signaling
• Nutrient sensing
• Intermediary metabolism
• +۱۱ مورد دیگر

Kristina Schoonjans is an Associate Professor at EPFL’s School of Life Sciences, where she leads the Laboratory of Metabolic Signaling (UPSCHOONJANS). Her research focuses on the molecular mechanisms of bile acid signaling, nutrient sensing, and intermediary metabolism, particularly in the context of metabolic disorders such as obesity, fatty liver disease, and cancer. She investigates how the liver-gut-brain axis integrates metabolic signals through nuclear receptors and mitochondrial dynamics. Her research interests include: Bile acid signaling and its role as a hormonal regulator Nutrient and metabolite sensing in energy homeostasis Intermediary metabolism and metabolic disorders Role of nuclear receptors (e.g., TGR5, LRH-1) in liver, gut, and adipose tissue Mitochondrial dynamics and fission in metabolic regulation Organoid models for studying liver and intestinal metabolism Systems genetics using BXD mouse populations The most recent articles highlight a strong focus on bile acid signaling, particularly through TGR5 and LRH-1, in regulating metabolic health. Themes include the conversion of white fat to beige fat (beiging), hepatic tumorigenesis, mitochondrial fission, and the use of organoid and genetically engineered mouse models. There is a consistent emphasis on translational applications for obesity, fatty liver disease, and cancer. Scientific honors include: Windaus Prize from the Dr. Falk Foundation (2010, shared with Johan Auwerx) for the discovery of the signaling/endocrine function of bile acids Prof. Schoonjans actively supervises PhD students and has advised numerous doctoral candidates who have since completed their theses. Her lab is supported by multiple grants from Swiss and international funding agencies, including the Swiss National Science Foundation, EPFL, CONACYT, and the Foundation for Health and Education. She teaches in several doctoral programs at EPFL, including Life Sciences Engineering, and contributes to education through the SSV and EDBB/EDCB/EDMS-ENS programs. The Schoonjans Lab brings together scientists, doctoral assistants, and technicians working on projects related to metabolic signaling. The team uses advanced techniques such as genetically modified mouse models, organoid cultures, and multi-omics (metabolomics, proteomics, transcriptomics) to study the liver-gut and brain-liver axes. The lab has a strong track record of high-impact publications and collaborations with institutions worldwide.

Guillermo A. Ameerمشاهده پروفایل

استاد

• Tissue Engineering
• Regenerative Engineering
• Biomaterials
• +۷ مورد دیگر

Guillermo A. Ameer serves as the Daniel Hale Williams Professor of Biomedical Engineering at Northwestern University's McCormick School of Engineering and Professor of Surgery in the Feinberg School of Medicine. He directs the Center for Advanced Regenerative Engineering (CARE) and maintains affiliations with the Simpson-Querrey Institute, Chemistry of Life Processes Institute, and the IBiS Graduate Program. His leadership extends to founding the Regenerative Engineering Laboratory, which pioneered citrate-based antioxidant biomaterials known as polydiolcitrates. Americas' leading innovator in regenerative engineering, Ameer's research spans vascular, orthopaedic, and bladder tissue engineering. His lab developed Nanonets™ thermoresponsive oligomers and photoresponsive liquid polymers for applications including wound healing, islet transplantation, and 3D-printed vascular scaffolds. Notable breakthroughs include bioresorbable stents, bladder regeneration scaffolds, and diabetic wound healing technologies that have received FDA clearance and commercial implementation through companies like Acuitive Technologies and VesselTek BioMedical. His publication record demonstrates consistent innovation in biomaterials science, with research trends showing progression from fundamental polymer chemistry to sophisticated clinical applications. Recent work focuses on electroactive bladder scaffolds, 3D-printed vascular devices, and wearable health monitoring systems, reflecting his commitment to translating laboratory discoveries into tangible medical solutions. The 2025 launch of the Regenerative Engineering Institute underscores his growing institutional impact. Percy L. Julian Award (2024) BMES Athanasiou Medal of Excellence in Translational Bioengineering (2023) Election to National Academy of Medicine (2021) National Academy of Inventors Fellow (2019) AAAS Fellow (2018) AIChE Fellow (2017) Ameer has mentored over 30 PhD and Master's students who now lead research at institutions including Penn State, USC, and the FDA. His lab secures substantial NIH funding, including an American Recovery and Reinvestment Act Challenge Grant for liquid cast arterial stents. Current projects include the development of citrate-based biomaterials for bladder regeneration, diabetic wound healing, and bioresorbable vascular scaffolds, with multiple technologies transitioning to clinical applications through partnerships with medical device companies. The Regenerative Engineering Laboratory maintains a collaborative interdisciplinary environment with approximately 20 researchers spanning engineering and natural sciences disciplines. Recent initiatives include the development of wearable skin gas sensors (2025) and CITREPORE™ bone void filler (2024), demonstrating the lab's capacity to address diverse clinical challenges through biomaterials innovation.

Eduardo N. Chiniمشاهده پروفایل

استاد

• Metabolism
• NAD Metabolism
• Aging
• +۱۱ مورد دیگر

Eduardo N. Chini, M.D., Ph.D., is a Professor at Mayo Clinic with primary and joint appointments in the Department of Anesthesiology and Perioperative Medicine and the Department of Cancer Biology. He is based in Rochester, Minnesota, and leads a research program focused on NAD metabolism, aging, and their roles in diseases such as cancer, obesity, and kidney disease. Education: BS in Biology, Centro Educacional de Niteroi-RJ MD, Universidade do Rio de Janeiro PhD in Biological Chemistry, Universidade do Rio de Janeiro Fellow, Department of Physiology and Biophysics, Mayo Clinic Resident in Anesthesiology, Mayo Clinic College of Medicine Research Interests: Eduardo N. Chini's research investigates the central role of nicotinamide adenine dinucleotide (NAD) in cellular metabolism, aging, and disease. His lab has made foundational discoveries in NAD catabolism, identifying CD38 as the primary enzyme regulating NAD levels in mammals. His work explores SIRT1 regulation via CD38 and DBC1, NAD metabolism in cancer, and its implications in polycystic kidney disease. He is particularly interested in how NAD signaling influences aging, metabolic syndrome, and organ dysfunction. Recent Research Trends: His recent publications (2023–2025) reveal a strong focus on the role of CD38 in aging, immune function, and tissue metabolism. Key themes include NAD+ depletion triggering inflammatory responses, CD38 inhibition as a therapeutic strategy for cardiotoxicity and metabolic aging, and the interplay between senescence, stem cell function, and mitochondrial health. His work increasingly integrates translational models with molecular mechanisms in aging and cancer. Scientific Awards: Florida Investigator of the Year, Mayo Clinic (2024) Glenn/AFAR Breakthroughs in Gerontology Award (2007) Edward C. Kendall Award, Mayo Clinic Alumni Association (2002) Directors Award for Aging Research, Kogod Center on Aging (2018) Distinguished Scientist Seminar Series, Georgetown Medical School (2022) Grants and Leadership: Dr. Chini is a co-Principal Investigator on multiple NIH-funded grants, including projects on CD38 in scleroderma, CLL, and male reproductive aging. He is Co-Director of the Mayo Clinic Mitochondrial Care Center and Associate Director of the Robert and Arlene Kogod Center on Aging. He has served on numerous national review panels and advisory councils, including the NIH Hepatobiliary Pathophysiology Study Section and AFAR's National Scientific Advisory Council. Labs and Teams: Dr. Chini leads a research laboratory at Mayo Clinic focused on NAD metabolism and aging. His team collaborates extensively with experts in cancer biology, mitochondrial medicine, and aging research. He is affiliated with the Mayo Clinic Comprehensive Cancer Center, the Kogod Center on Aging, and the Robert M. and Billie Kelley Pirnie Translational PKD Center.

Laura Ruscheمشاهده پروفایل

استاد

• Chromatin Biology
• Gene Expression Regulation
• Evolutionary Genomics
• +۳ مورد دیگر

Laura Rusche is a Professor in the Department of Biological Sciences at the University at Buffalo. Her research focuses on chromatin structure, gene expression regulation, and evolutionary mechanisms in yeast. She investigates how sirtuins and heterochromatin proteins like Sir3 contribute to epigenetic control and respond to metabolic stress. Her work spans multiple yeast species to understand evolutionary adaptations in protein functions and transcriptional circuits. Education: BS from Yale University (Molecular Biophysics & Biochemistry), PhD from Johns Hopkins University (Biochemistry), and postdoctoral training at UC Berkeley. Research Interests: Chromatin dynamics, sirtuin-mediated epigenetic regulation, gene duplication consequences, and fungal pathogen biology. Key projects include studying Sir2's role in NAD+ stress responses and the evolution of Sir3 from replication proteins. Lab: The Rusche Lab explores centromere stability, heterochromatin formation in Candida species, and evolutionary genomics. Recent work highlights unique centromere structures in Candida auris and the functional divergence of sirtuins across yeasts.

Stephen L Helfandمشاهده پروفایل

استاد

• Molecular Genetics of Aging
• Longevity
• Neurodegeneration
• +۷ مورد دیگر

Stephen L Helfand is the George D. Eggleston Endowed Professor of Biochemistry at Brown University, where he serves as Professor in the Department of Molecular Biology, Cell Biology and Biochemistry and Vice-Chair of Research in the Department of Neurology. His work focuses on the molecular genetics of aging , using Drosophila melanogaster to investigate how chromatin changes, transposable elements, and metabolic pathways like the INDY gene influence longevity and age-related diseases. Education: BS (1975) and MD (1979) from Stanford University and Albert Einstein College of Medicine Key Research Areas: Mechanisms of aging Chromatin remodeling Transposable elements in aging Metabolic regulation of lifespan Neurodegenerative disease models His 15 most recent articles (2019-2011) highlight interdisciplinary work bridging genetics, epigenetics, and metabolism. Common themes include chromatin dynamics , mitochondrial function , and transposable element activation in aging, with applications to human diseases like Alzheimer's. Scientific Awards Glenn Awards (2007-2009, 2014-2016) MERIT Award (2004-2016) Fellow of AAAS (2017) and Gerontological Society of America (2017) NIH grants (R01AG067306, R01AG024353, P01AG051449) He contributes to translational neuroscience and aging research through affiliations with Brown University's Center for Computational Molecular Biology , Carney Institute for Brain Science , and Center for Translational Neuroscience . His lab has developed rapid assays for lifespan-extending interventions and demonstrated connections between sirtuins, caloric restriction, and p53 regulation.

Richard F. Loeser, Jr.مشاهده پروفایل

استاد

• Osteoarthritis (OA) mechanisms
• Cartilage cell biology
• Redox regulation of cell signaling
• +۴ مورد دیگر

Dr. Richard F. Loeser, Jr. is the Joseph P. Archie, Jr. Eminent Professor of Medicine and Director of the UNC Thurston Arthritis Research Center at the University of North Carolina School of Medicine. His research focuses on osteoarthritis (OA) mechanisms, particularly the role of oxidative stress, aging, and cellular signaling in joint degeneration. He has pioneered studies on redox regulation of chondrocyte signaling and integrin function, using both in vitro and rodent models. Education: Undergraduate: Virginia Tech Medical School: West Virginia University Residency/Fellowship: Wake Forest Baptist Medical Center Research interests include OA biomarkers, exercise interventions, and gut microbiota's role in joint health. His clinical work emphasizes translating basic science discoveries into therapeutic strategies, including weight loss and exercise programs for knee OA patients. He leads multidisciplinary teams studying OA phenotypes and metabolomics. Publications reflect a blend of clinical trials (e.g., START trial on strength training) and mechanistic studies on cellular senescence and Sirt6 pathways. He holds leadership roles in arthritis research and has contributed to major reviews defining OA as a systemic joint disease.

• Metabolic Disorders
• Hepatology
• Lipid Metabolism
• +۳ مورد دیگر

Dr. Yingdong Zhu is a Researcher in the Department of Pediatrics at Yale School of Medicine, Yale University. His work focuses on metabolic disorders, particularly nonalcoholic steatohepatitis (NASH), lipid metabolism, and atherosclerosis. He investigates molecular mechanisms involving transcription factors (e.g., ATF3, HNF4α), miRNAs, and retinoic acid receptors in metabolic and liver diseases. His research integrates hepatocyte, adipocyte, and macrophage biology to elucidate pathways linking metabolic dysfunction to cardiovascular and hepatic pathologies. Research interests include: Adipose-liver crosstalk in metabolic disorders Molecular regulation of NASH progression Role of retinoid signaling in atherosclerosis MicroRNA-mediated liver disease mechanisms No specific awards or grants are listed, but his contributions are evident through recent publications in metabolic and hepatic research. Advising roles or lab affiliations are not explicitly stated in available texts.

Kevin Pruittمشاهده پروفایل

دانشیار

• Wnt signaling
• Dishevelled proteins
• Cancer epigenetics
• +۴ مورد دیگر

Kevin Pruitt is an Associate Professor in the Department of Pharmacology at the University of North Carolina School of Medicine . His research bridges cancer epigenetics , Wnt signaling , and aromatase regulation , with a focus on understanding how epigenetic enzymes modulate oncogenic pathways and tumor-immune interactions. Key projects include: Elucidating epigenetic drivers in cancer progression and immune evasion Investigating nuclear and cytosolic roles of Dishevelled proteins in Wnt signaling Decoding mechanisms of aromatase dysregulation in breast cancer Research Trends : Recent publications highlight his work on the tumor microenvironment (e.g., cryoablation-induced immune changes, Sertoli cell immunoregulation) and nuclear Wnt signaling (e.g., Dishevelled localization, transcriptional targets). His studies often intersect with epigenetic therapies and hormone-sensitive cancers . Education & Affiliation : While specific educational details are not provided, his academic career spans institutions like LSU Health Sciences Center and UNC Chapel Hill. He leads the Pruitt Lab , focusing on epigenetic and Wnt pathway interactions. Collaborative Networks : Frequent co-authors include experts in cancer biology, immunology, and molecular genetics, such as Drs. Layeequr Rahman, Suresh Ramachandran, and Sandra Almodovar.

Vernon Dolinskyمشاهده پروفایل

استاد

• Developmental Origins of Health and Disease
• Gestational Diabetes
• Diabetes
• +۱۰ مورد دیگر

Vernon Dolinsky is a Professor and Associate Department Head in the Department of Pharmacology and Therapeutics at the Max Rady College of Medicine, University of Manitoba. He is also a Research Scientist at the Children’s Hospital Research Institute of Manitoba (CHRIM) and co-leads the pediatric diabetes research theme within the Diabetes Research Envisioned and Accomplished in Manitoba (DREAM) group. Education: Bachelor of Science (Honours), University of Manitoba (1996) Master of Science, University of Manitoba (1998) PhD in Biochemistry, University of Alberta (2003) Postdoctoral Fellowships: University of Michigan and University of Alberta Dr. Dolinsky's research focuses on the developmental origins of metabolic and cardiovascular diseases, particularly how gestational diabetes influences obesity, diabetes, and heart disease risk in offspring. His lab uses advanced techniques including animal models, in vivo imaging, genomics, and epigenomics to explore cellular mechanisms involving insulin signaling, mitochondrial function, and sirtuin regulation. His work is supported by the Canadian Institutes of Health Research (CIHR), and he actively mentors summer students, Master's, and PhD candidates. Though no specific publications are listed, his research spans diabetes, obesity, pregnancy complications, and molecular pharmacology, with strong implications for early-life interventions and therapeutic development. Scientific Awards: Manitoba Medical Services Foundation, Allen Rouse Career Development Award (2017–2020) Ken Hughes Young Investigator Award for Medical Research (2016) University of Manitoba Faculty Association Merit Award (2016) Diabetes Foundation of Manitoba, Dr. J.A. Moorhouse Fellowship Award (2014–2017) Stewart Whitman-Amgen Young Investigator Award (2014) Dr. Dolinsky is actively involved in advising graduate students and securing competitive research grants, including continuous funding from CIHR. His leadership extends to collaborative research networks like DREAM, where he contributes to advancing pediatric diabetes research in Manitoba. He is affiliated with key research entities including CHRIM and the Max Rady College of Medicine, working within interdisciplinary teams focused on metabolic health across the lifespan.

Nafees Ahemadمشاهده پروفایل

دانشیار

• Medicinal Chemistry
• Antiviral Agents
• Drug Design
• +۴ مورد دیگر

Dr. Nafees Ahemad is an Associate Professor at Monash University Malaysia's Malaysia School of Pharmacy. He holds a PhD in Natural Products Chemistry/Medicinal Chemistry from NIPER, India, and has postdoctoral experience at Universiti Sains Malaysia. His research focuses on computational drug design, particularly targeting HIV, dengue, and cancer, with emphasis on antiviral agents and natural products. Dr. Ahemad has led or co-led nine research projects since 2013, including studies on sirtuin inhibitors for oral cancer and breast cancer imaging probes. He has published over 100 peer-reviewed articles and reviews, contributing to UN Sustainable Development Goals related to health and innovation. Key awards include the PVC’s Commendation for Excellence in Education (2021) and the Supervisor of the Year – Outstanding Nominee Award (2018). His work spans collaborations across multiple countries, with notable contributions to enzyme inhibition mechanisms and drug discovery. Current projects address drug-resistant cancers, anti-HIV agents, and chikungunya virus research. Dr. Ahemad also advocates for active learning methods in pharmacy education. Publications highlight advancements in nanomedicine, enzyme modulation, and repurposing existing drugs for cancer. His interdisciplinary approach integrates computational modeling, medicinal chemistry, and biological assays to develop novel therapeutics.

Xuming Zhangمشاهده پروفایل

استاد

• Molecular Biology
• Virology
• Coronavirus Pathogenesis
• +۵ مورد دیگر

Xuming Zhang is a Professor in the Department of Microbiology and Immunology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. He holds a Ph.D. from Justus-Liebig University of Giessen, Germany, with postdoctoral training at Louisiana State University and the University of Southern California School of Medicine. His research focuses on understanding molecular mechanisms of coronavirus pathogenesis, particularly using murine coronavirus (MHV) as a model to study multiple sclerosis and neurodegenerative diseases. Key interests include viral RNA persistence in central nervous system (CNS) cells, viral-induced apoptosis in oligodendrocytes, and regulation of viral RNA synthesis through cellular signaling pathways such as MEK/ERK. His lab also explores antiviral drug discovery and development of viral vectors for vaccine applications. Recent work highlights studies on resveratrol's antiviral effects via sirtuins, identification of anti-coronavirus compounds, and analysis of coronavirus stability on food surfaces. His research bridges molecular virology, neuroimmunology, and host-pathogen interactions, with implications for developing therapies against viral CNS infections. Dr. Zhang's laboratory investigates cellular gene regulation during coronavirus infection, including over 200 differentially expressed genes identified via microarray analysis. Current efforts focus on mechanisms linking viral persistence to oligodendrocyte dysfunction and the role of transcription factors like Egr-1 in viral replication.

Leonard P. Guarenteمشاهده پروفایل

استاد

• Aging Research
• Neuroscience
• Molecular Biology
• +۳ مورد دیگر

Leonard P. Guarente is the Novartis Professor of Biology at the Massachusetts Institute of Technology (MIT), affiliated with the Department of Biology in the College of Science. His research focuses on the genetic and molecular mechanisms underlying aging and age-related diseases, such as Alzheimer’s and muscular dystrophy. He employs bioinformatics and functional analyses to study aging pathways in mammals, particularly in brain regions and muscle tissues. Guarente’s work has identified key roles for sirtuins, NAD+ metabolism, and epigenetic regulation in longevity and disease. Education: PhD in 1978 from Harvard University, SB in Biology in 1974 from MIT. Research Interests: Aging biology, neurodegenerative diseases, metabolic pathways, epigenetic regulation, and sirtuin function. His lab investigates how genetic pathways influence aging processes and explores therapeutic interventions for age-related pathologies. Publications Highlight: Over 150 publications, including seminal papers on SIRT1’s role in fat metabolism, aging in C. elegans, and NAD+ dependent deacetylases. Recent work focuses on Alzheimer’s disease risk factors and muscular dystrophy treatments. Awards: Multiple honors, including the Feodor Lynen Award (2012), Charles H. Best Lectureship (2011), and election to the French Academy of Sciences (2009). Labs/Teams: His lab at MIT’s Koch Institute integrates computational and experimental approaches to study aging mechanisms. Collaborates widely, including with Kellis (computational biology) and Satoh (neuroscience).

• Systems Biology
• Metabolic Modeling
• NAD Metabolism
• +۷ مورد دیگر

Ines Heiland is a Professor at the Department of Biomedicine, Faculty of Medicine, University of Bergen. Her research integrates systems biology and computational modeling to investigate metabolic networks, with a focus on NAD and tryptophan metabolism, mitochondrial function, and circadian regulation. University: University of Bergen School: Faculty of Medicine Department: Department of Biomedicine Position: Professor Email: i.heiland@uib.no Her educational background is not explicitly detailed in the provided texts, but her extensive research and supervisory roles indicate a strong academic foundation in systems biology and molecular metabolism. Ines Heiland's research centers on understanding how metabolic networks regulate cellular health and disease. She employs computational models to study NAD homeostasis, tryptophan catabolism, and their roles in aging, cancer, and neurodegenerative conditions. Her work emphasizes the integration of multi-omics data and kinetic modeling to uncover regulatory mechanisms in metabolic pathways. The recent articles highlight a consistent focus on NAD metabolism, metabolic modeling, and the interplay between metabolism and epigenetics. Themes include the evolution of metabolic pathways, subcellular compartmentation of metabolites, and the development of bioinformatics tools for metabolic analysis. Her publications span from algorithm development (e.g., GEMCAT) to physiological insights in aging and disease. She has contributed to editorial and review work, such as the 2020 editorial on systems biology challenges and the 2015 review on NAD metabolism dynamics, underscoring her leadership in the field. Supervised PhD student: Mathias Bockwoldt Ines Heiland has been involved in collaborative research projects, often in partnership with institutions like UiT The Arctic University of Norway. She participates in networks such as NORBIS and BioCat, contributing to interdisciplinary efforts in biotechnology and systems biology. Her work involves both theoretical modeling and experimental validation, particularly in the context of marine biomass conversion and Arctic bioplastics.

• Medicinal Chemistry
• Organic Synthesis
• Drug Discovery
• +۴ مورد دیگر

Keng Yoon Yeong is a Senior Lecturer in the School of Science at Monash University, specializing in Medicinal Chemistry and Advanced Organic Chemistry. His research focuses on small molecule and short peptide drug discovery targeting cancers, infectious diseases, and neurological disorders. Prior to academia, he spent 11 years as a research scientist in industry, focusing on organic synthesis and immunoassays. His work is supported by international and national funders like the Royal Society of Chemistry UK and Malaysian Ministry of Science, Technology and Innovation (MOSTI). He has co-authored over 60 publications and holds several awards, including the Faculty of Science Dean's Awards for Excellence in Teaching (2020) and Honours Supervision (2023). His research group employs parallel synthesis for compound libraries and explores strategies like computer-aided drug design and bioisosteric replacements. Recent projects include developing ADAR1 inhibitors for oral cancers and isolating bioactive compounds from Myristica fragrans for Alzheimer’s treatment. He actively collaborates internationally and has visited institutions like the University of Northern British Columbia (2024) and Petru Poni Institute of Macromolecular Chemistry (2024). Awards include the Golden Pavilion Award for Best Research Project and Thesis from University Science Malaysia (2015–2016), and recognition for sustainable drug discovery initiatives. His media engagements include TEDx talks and features on drug discovery trends.